Informe del mercado de vacunas de viaje por composición (monovacinas, vacunas combinadas), enfermedad (hepatitis A, DPT, fiebre amarilla, tifus, hepatitis B, sarampión, rabia, meningococo, varicela, encefalitis japonesa, y otros), y región 2024-2032

Informe del mercado de vacunas de viaje por composición (monovacinas, vacunas combinadas), enfermedad (hepatitis A, DPT, fiebre amarilla, tifus, hepatitis B, sarampión, rabia, meningococo, varicela, encefalitis japonesa, y otros), y región 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A16861

Language of the Report – English

Sin embargo, el informe puede estar disponible en español por un costo adicional.

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Travel Vaccines Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Composition
    5.5    Market Breakup by Disease 
    5.6    Market Breakup by Region
    5.7    Market Forecast
6   Market Breakup by Composition 
    6.1    Mono Vaccines 
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Combination Vaccines 
        6.2.1    Market Trends
        6.2.2    Market Forecast
7   Market Breakup by Disease 
    7.1    Hepatitis A  
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    DPT  
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Yellow Fever
        7.3.1    Market Trends
        7.3.2    Market Forecast
    7.4    Typhoid 
        7.4.1    Market Trends
        7.4.2    Market Forecast
    7.5    Hepatitis B
        7.5.1    Market Trends
        7.5.2    Market Forecast
    7.6    Measles and Mumps
        7.6.1    Market Trends
        7.6.2    Market Forecast
    7.7    Rabies
        7.7.1    Market Trends
        7.7.2    Market Forecast
    7.8    Meningococcal
        7.8.1    Market Trends
        7.8.2    Market Forecast
    7.9    Varicella
        7.9.1    Market Trends
        7.9.2    Market Forecast
    7.10    Japanese Encephalitis
        7.10.1    Market Trends
        7.10.2    Market Forecast
    7.11    Others
        7.11.1    Market Trends
        7.12.2    Market Forecast
8   Market Breakup by Region
    8.1    North America 
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Europe 
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Asia Pacific 
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Middle East and Africa
        8.4.1    Market Trends
        8.4.2    Market Forecast
    8.5    Latin America
        8.5.1    Market Trends
        8.5.2    Market Forecast
9   Global Travel Vaccines Industry: SWOT Analysis 
    9.1    Overview 
    9.2    Strengths
    9.3    Weaknesses 
    9.4    Opportunities
    9.5    Threats
10  Global Travel Vaccines Industry: Value Chain Analysis 
    10.1    Exploratory Stage
    10.2    Preclinical and Clinical Development
    10.3    Regulatory Approval
    10.4    Manufacturing
    10.5    Marketing and Distribution
11  Global Travel Vaccines Industry: Porters Five Forces Analysis 
    11.1     Overview 
    11.2     Bargaining Power of Buyers
    11.3     Bargaining Power of Suppliers 
    11.4     Degree of Competition
    11.5     Threat of New Entrants
    11.6     Threat of Substitutes
12  Global Travel Vaccines Industry: Price Analysis 
13  Travel Vaccines Manufacturing Process

    13.1    Product Overview
    13.2    Raw Material Requirements
    13.3    Manufacturing Process
    13.4    Key Success and Risk Factors
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    GlaxoSmithKline Pharmaceuticals Limited  
        14.3.2    Sanofi Pasteur  
        14.3.3    Merck & Co., Inc. 
        14.3.4    Novartis AG  
        14.3.5    Pfizer Inc.   
        14.3.6    ALK-Abelló A/S  
        14.3.7    Bavarian Nordic A/S   
        14.3.8    Crucell (Subsidiary of Johnson & Johnson)  
        14.3.9    CSL Limited  
        14.3.10    AstraZeneca PLC  
        14.3.11    Altimmune, Inc.  
        14.3.12    Abbott Laboratories  
        14.3.13    Hoffmann-La Roche, Inc.

Informe del mercado de vacunas de viaje por composición (monovacinas, vacunas combinadas), enfermedad (hepatitis A, DPT, fiebre amarilla, tifus, hepatitis B, sarampión, rabia, meningococo, varicela, encefalitis japonesa, y otros), y región 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials